Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
- PMID: 9425903
- DOI: 10.1038/ng0198-65
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
Abstract
Telomerase is a specialized type of reverse transcriptase which catalyzes the synthesis and extension of telomeric DNA (for review, see ref.1). This enzyme is highly active in most cancer cells, but is inactive in most somatic cells. This striking observation led to the suggestion that telomerase might be important for the continued growth or progression of cancer cells. However, little is known about the molecular mechanism of telomerase activation in cancer cells. Human telomerase reverse transcriptase (hTRT) has recently been identified as a putative human telomerase catalytic subunit. We transfected the gene encoding hTRT into telomerase-negative human normal fibroblast cells and demonstrated that expression of wild-type hTRT induces telomerase activity, whereas hTRT mutants containing mutations in regions conserved among other reverse transcriptases did not. Hepatocellular carcinoma (20 samples) and non-cancerous liver tissues (19 samples) were examined for telomerase activity and expression of hTRT, the human telomerase RNA component (hTR; encoded by TERC) and the human telomerase-associated protein (hTLP1; encoded by TEP1). A significant correlation between hTRT expression and telomerase activity was observed. These results indicate that the hTRT protein is the catalytic subunit of human telomerase, and that it plays a key role in the activation of telomerase in cancer cells.
Similar articles
-
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.Nat Genet. 1997 Dec;17(4):498-502. doi: 10.1038/ng1297-498. Nat Genet. 1997. PMID: 9398860
-
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.Cancer Res. 1998 Apr 1;58(7):1558-61. Cancer Res. 1998. PMID: 9537264
-
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.Cancer Res. 2001 Jul 15;61(14):5529-36. Cancer Res. 2001. PMID: 11454703
-
Expression of telomerase genes in thyroid carcinoma.Int J Oncol. 2002 Aug;21(2):265-72. Int J Oncol. 2002. PMID: 12118320 Review.
-
[Structure and regulation mechanisms of telomerase].Nihon Rinsho. 1998 May;56(5):1102-7. Nihon Rinsho. 1998. PMID: 9613104 Review. Japanese.
Cited by
-
The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment.PLoS One. 2012;7(6):e39292. doi: 10.1371/journal.pone.0039292. Epub 2012 Jun 15. PLoS One. 2012. PMID: 22720091 Free PMC article.
-
Prognostic Alternative Splicing Signatures in Esophageal Carcinoma.Cancer Manag Res. 2021 Jun 4;13:4509-4527. doi: 10.2147/CMAR.S305464. eCollection 2021. Cancer Manag Res. 2021. PMID: 34113176 Free PMC article. Review.
-
Strict control of telomerase activation using Cre-mediated inversion.BMC Biotechnol. 2006 Feb 20;6:10. doi: 10.1186/1472-6750-6-10. BMC Biotechnol. 2006. PMID: 16504006 Free PMC article.
-
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.Mol Cell Biol. 2001 Nov;21(22):7775-86. doi: 10.1128/MCB.21.22.7775-7786.2001. Mol Cell Biol. 2001. PMID: 11604512 Free PMC article.
-
Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.BMC Cancer. 2006 Aug 15;6:206. doi: 10.1186/1471-2407-6-206. BMC Cancer. 2006. PMID: 16911782 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
